
zzso is an experimental intravenous zzso under study for the prevention or treatment of osteoporosis and skeletal complications of bone zzso as well as zzso of zzso To review the data on this drug, zzso was searched for pertinent studies in zzso data from January zzso 2005 were zzso In zzso studies, zzso was an extremely potent zzso compared with its predecessors and was active in all animal models of human zzso and zzso zzso Similar to other zzso zzso exhibits zzso activity and prevents or reduces bone zzso Forty to fifty percent of the dose is bound to zzso zzso clearance of unchanged drug accounts for zzso of total body zzso Early clinical trials demonstrated efficacy and zzso of intravenous zzso in the prevention or treatment of zzso and zzso osteoporosis when administered once every 3 zzso zzso zzso also reduces skeletal complications of bone zzso including pain, although the cumulative dose used is much higher than that used in zzso as the drug is administered every zzso zzso Single doses of intravenous zzso are probably also effective in the treatment of zzso of zzso The major zzso issue with intravenous zzso is zzso safety, thus the drugs generally require infusion zzso zzso zzso for zzso acid, zzso zzso for zzso However, intravenous zzso can be administered by zzso injection over a few minutes without an elevated risk of zzso The experimental intravenous dosage is 2 zzso every 3 months for treatment or prevention of zzso and 2-6 zzso every zzso weeks or in a single dose for treatment of bone zzso or zzso of zzso zzso zzso can be used in the presence of severe zzso impairment with proper dosage zzso The drug will be an interesting addition to the available drugs for zzso bone zzso and zzso of zzso Studies of intravenous zzso as an zzso treatment for zzso that tend to zzso to bone are under zzso Whether intravenous zzso will be a therapeutic advance is best answered by randomized, controlled zzso These are ongoing and should provide data with which to make zzso choices concerning intravenous zzso 

